DEVELOPMENT OF A COMPOUND FOR THE TREATMENT OF COVID-19
DEVELOPMENT OF A COMPOUND FOR THE TREATMENT OF COVID-19
开发治疗 COVID-19 的化合物
批准号：
10933185
负责人：
STANLEY WANG
金额：
$846.95万
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
项目状态：
未结题
起止时间：
2023-09-22 至 2026-02-15
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To support the advanced development of a promising antiviral against a pathogen with pandemic potential. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
